4//SEC Filing
Nexvet Biopharma plc 4
Accession 0001572426-17-000011
CIK 0001618561operating
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 11:20 AM ET
Size
7.8 KB
Accession
0001572426-17-000011
Insider Transaction Report
Form 4
Hanna Ashraf
Director
Transactions
- Exercise/Conversion
Ordinary Shares
2017-03-31$0.13/sh+500$63→ 11,920 total - Exercise/Conversion
Restricted Share Units
2017-03-31−500→ 500 totalExercise: $0.13Exp: 2019-07-01→ Ordinary Shares (500 underlying)
Holdings
- 1,500(indirect: By Trust)
Ordinary Shares
Footnotes (1)
- [F1]500 of the Restricted Share Units vested and became convertible on 03/31/17, and 500 Restricted Share Units shall vest and become convertible on 6/30/17, subject to payment of the nominal value per share to Issuer within 30 days of vesting.
Documents
Issuer
Nexvet Biopharma plc
CIK 0001618561
Entity typeoperating
IncorporatedIreland
Related Parties
1- filerCIK 0001618561
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 11:20 AM ET
- Size
- 7.8 KB